Your browser doesn't support javascript.
loading
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study.
Leukemia ; 27(10): 2032-9, 2013 Oct.
Article in En | MEDLINE | ID: mdl-23860450

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasm, Residual / Janus Kinase 2 / Real-Time Polymerase Chain Reaction / Mutation / Myeloproliferative Disorders / Neoplasm Recurrence, Local Type of study: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasm, Residual / Janus Kinase 2 / Real-Time Polymerase Chain Reaction / Mutation / Myeloproliferative Disorders / Neoplasm Recurrence, Local Type of study: Clinical_trials / Diagnostic_studies / Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom